中国药房2017，Vol.28Issue(10)：1297-1301,5.DOI:10.6039/j.issn.1001-0408.2017.10.01
基于结构-行为-绩效分析范式的药品流通领域供给侧结构性改革策略分析
Analysis on Supply-side Structural Reform Strategy of Drug Distribution Based on Structure-conduct-per-formance Analysis Paradigm
摘要
Abstract
OBJECTIVE:To provide basic industrial research and development recommendations for the supply-side structural reform in drug distribution in China. METHODS:Structure-conduct-performance(SCP)analysis paradigm from Harvard was used for in-depth study of market structure,business conduct and business performance in China since 2010. RESULTS:Since 2010, drug distribution industry in China had shown the scale of decline in the growth rate,low market concentration,increased barriers to entry,the leading of state-owned capital,etc. Though corporate mergers and acquisitions and public financing expanded the scale,management information,third-party logistics,"Internet+"and pharmacy alliance business model flourished,the industry op-erating performance was poor,state-owned enterprises showed poor performance. CONCLUSIONS:The transformation and upgrad-ing of the industry business model should be promoted by targetedly accelerating the supply-side structural reforms in the drug distri-bution industry,encouraging corporate finance mergers,breaking local protectionism,developing cooperative pharmacies and phar-maceutical third-party logistics alliances and leveraging the Internet.关键词
结构-行为-绩效分析/药品流通/供给侧改革/产业结构升级Key words
Structure-conduct-performance analysis/Drug distribution/Supply-side reform/Industry structure upgrading分类
医药卫生引用本文复制引用
李璠,余伯阳,曹人元,曹亚茹,洪亮..基于结构-行为-绩效分析范式的药品流通领域供给侧结构性改革策略分析[J].中国药房,2017,28(10):1297-1301,5.基金项目
国家社会科学基金项目(No.14BGL144) （No.14BGL144）
云南省天然药物药理重点实验室开放基金(No.2015G001) （No.2015G001）
